The Na+-D-glucose cotransporters SGLT1 and SGLT2 are targets for the treatment of diabetes and cancer

Published 2017 View Full Article

  1. Home
  2. Publications
  3. Publication Search
  4. Publication Details
Title
The Na+-D-glucose cotransporters SGLT1 and SGLT2 are targets for the treatment of diabetes and cancer
Authors
Keywords
Na, -D-glucose cotransporter, Glucose sensor, SLC5-family, SGLT-inhibitors, Antidiabetic therapy, Anticancer therapy
Journal
PHARMACOLOGY & THERAPEUTICS
Volume 170, Issue -, Pages 148-165
Publisher
Elsevier BV
Online
2016-10-21
DOI
10.1016/j.pharmthera.2016.10.017

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Reprint

Contact the author

Discover Peeref hubs

Discuss science. Find collaborators. Network.

Join a conversation

Find the ideal target journal for your manuscript

Explore over 38,000 international journals covering a vast array of academic fields.

Search
Webinars Posters Questions Hubs Funding Journals Articles Connect Collections Reviewers About Us FAQs Mobile App Privacy Policy Terms of Use
© Peeref 2019-2024. All rights reserved.